Figure 5
From: [18F]-Labeled PARP-1 PET imaging of PSMA targeted alpha particle radiotherapy response
Rapid Uptake in [225Ac]-PSMA-617 Treated Tumors: The tumor specific activity concentration of the PARP-1 tracer was determined in treated and control mice co-injected on camera. The results indicate a trend of more rapid uptake of [18F]-PAPRZ in tumors treated with alpha particle emitting [225Ac]-PSMA-617 (red) over control saline treated subjects (black).
